Dried Blood Spot (DBS) sampling is increasingly used as a minimally invasive tool to acquire a representative blood sample in the context of therapeutic drug monitoring (TDM) and toxicology. However, the analysis of DBS is associated with several issues, such as contamination risk, blood volume spotted, blood spot homogeneity and hematocrit (Hct). Of these, the Hct is undoubtedly the most widely discussed challenge, as strongly deviating Hct values may significantly impact DBS-based quantitation. First of all, the Hct strongly influences the spreading of a blood drop on filter paper, with higher Hct values leading to smaller, more concentrated spots. Second, the Hct may influence parameters such as recovery and matrix effect. Third, when DBS results are to be compared with those obtained from plasma, the distribution of an analyte in red blood cells and plasma needs to be examined on a caseby-case basis. These Hct-associated issues make that, when compared to conventional plasma analysis, DBS-based quantitation suffers from an additional unknown factor of uncertainty. Although some advocate the use of volumetrically applied spots, this approach is difficult to sustain when aiming at patient self-sampling. Hitherto, there is no approach that allows Hct prediction from non-volumetrically applied DBS.
• We developed and validated a procedure to predict the approximate Hct (LoA's of ±0.049, after bias correction) of DBS, based upon [K + ] measurement.
• Successful application of the procedure on 3-mm punches of DBS, derived from patient samples, demonstrated its practical applicability. Overview of the data for accuracy and inter-and intrabatch (n = 8 duplicate measurements) precision. A and B respectively give the data obtained for QCs (3 Hct levels) and LOQs (LLOQ and ULOQ), prepared from blood from the same donor (donor 1) as the one in which the calibrators were prepared. C gives the data for QCs prepared from blood from another donor than the one in which the calibrators were prepared. 
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Effect of punching site and blood volume on [K + ], tested at 3 Hct levels
The method was applied on blood samples from patients (n = 111):
• Li-heparin blood was used to generate 25-µl DBS • EDTA blood was used for routine Hct determination (Sysmex XE-5000) • subset of the patient samples (n=49) • Criterium: 2/3 of repeated analyses should lie within ± 20% of the mean of the repeated and the original analysis  FULFILLED!
Incurred sample reanalysis
• Being able to predict the Hct of any given DBS may render it possible in future to cope with -and possibly even to adjust for-the "hematocrit effect" in any given DBS-based analytical method.
• In future, this study should be extended to true capillary DBS. 
